About UpperMed
UpperMed is a company based in Singapore (Singapore) founded in 2016 by Lin Tzu Yang, Cheng Yi Chih, and Lee Yan You. It operates as a B2B. UpperMed has raised $80 thousand across 1 funding round from investors including Brinc. UpperMed operates in a competitive market with competitors including AWAK, Simergent, liberDi, Padmaseetha Technologies and Relavo, among others.
- Headquarter Singapore, Singapore
- Founders Lin Tzu Yang, Cheng Yi Chih, Lee Yan You
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Uppermed Pte. Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$80 K (USD)
in 1 rounds
-
Latest Funding Round
$80 K (USD), Seed
Aug 25, 2020
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of UpperMed
UpperMed has successfully raised a total of $80K through 1 strategic funding round. The most recent funding activity was a Seed round of $80 thousand completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in UpperMed
UpperMed has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Brinc.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture platform bridging entrepreneurs with investors catalyzing innovation into solutions
|
Locked | Locked | Locked |
Investor details for UpperMed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by UpperMed
Investment portfolio details for UpperMed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - UpperMed
Detailed financials for UpperMed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Uppermed Comparisons
Peer comparison for UpperMed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of UpperMed
UpperMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AWAK, Simergent, liberDi, Padmaseetha Technologies and Relavo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Develops innovative portable digital dialysis devices for healthcare.
|
|
| Locked | Locked | Locked |
Automated peritoneal dialysis systems are manufactured for home use.
|
|
| Locked | Locked | Locked |
Portable peritoneal dialysis systems are developed for end-stage kidney patients.
|
|
| Locked | Locked | Locked |
Connected renal dialysis devices are developed for peritoneal treatment.
|
|
| Locked | Locked | Locked |
Development of dialysis devices for kidney failure patients is conducted.
|
|
| Locked | Locked | Locked |
Develops innovative home-based devices for peritoneal dialysis treatments.
|
Detailed competitors of UpperMed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Uppermed
Complete news archive for UpperMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about UpperMed
UpperMed was founded in 2016 and raised its 1st funding round 4 years after it was founded.
UpperMed is headquartered in Singapore, Singapore.
Cheng Yi Chih is the current CEO of UpperMed. They have also founded this company.
UpperMed is a funded company, having raised a total of $80K across 1 funding round to date.
UpperMed develops innovative portable devices for peritoneal dialysis, improving patient care and accessibility through providing healthcare solutions, developing medical devices, dialysis technology, and portable solutions. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
UpperMed's top competitors include Simergent, liberDi and Padmaseetha Technologies.
UpperMed has 1 investor. Key investors include Brinc.